Literature DB >> 26333471

Prior inpatient admission increases the risk of post-operative infection in hepatobiliary and pancreatic surgery.

Zachary M Dong1, Alexis P Chidi1, Julie Goswami1, Katrina Han1, Richard L Simmons1, Matthew R Rosengart1, Allan Tsung1.   

Abstract

BACKGROUND: Hepatobiliary and pancreatic (HPB) operations have a high incidence of post-operative nosocomial infections. The aim of the present study was to determine whether hospitalization up to 1 year before HPB surgery is associated with an increased risk of post-operative infection, surgical-site infection (SSI) and infection resistant to surgical chemoprophylaxis.
METHODS: A retrospective cohort study of patients undergoing HPB surgeries between January 2008 and June 2013 was conducted. A multivariable logistic regression model was used for controlling for potential confounders to determine the association between pre-operative admission and post-operative infection.
RESULTS: Of the 1384 patients who met eligibility criteria, 127 (9.18%) experienced a post-operative infection. Pre-operative hospitalization was independently associated with an increased risk of a post-operative infection [adjusted odds ratio (aOR): 1.61, 95% confidence interval [CI]: 1.06-2.46] and SSI (aOR: 1.79, 95% CI: 1.07-2.97). Pre-operative hospitalization was also associated with an increased risk of post-operative infections resistant to standard pre-operative antibiotics (OR: 2.64, 95% CI: 1.06-6.59) and an increased risk of resistant SSIs (OR: 3.99, 95% CI: 1.25-12.73). DISCUSSION: Pre-operative hospitalization is associated with an increased incidence of post-operative infections, often with organisms that are resistant to surgical chemoprophylaxis. Patients hospitalized up to 1 year before HPB surgery may benefit from extended spectrum chemoprophylaxis.
© 2015 International Hepato-Pancreato-Biliary Association.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26333471      PMCID: PMC4644362          DOI: 10.1111/hpb.12499

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  49 in total

1.  The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs.

Authors:  K B Kirkland; J P Briggs; S L Trivette; W E Wilkinson; D J Sexton
Journal:  Infect Control Hosp Epidemiol       Date:  1999-11       Impact factor: 3.254

Review 2.  Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project.

Authors:  Dale W Bratzler; Peter M Houck
Journal:  Am J Surg       Date:  2005-04       Impact factor: 2.565

Review 3.  Antibiotic policies in surgery: a consensus paper.

Authors:  L S Stratchounski; E W Taylor; E P Dellinger; J C Pechere
Journal:  Int J Antimicrob Agents       Date:  2005-10       Impact factor: 5.283

Review 4.  Management of multidrug-resistant organisms in health care settings, 2006.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

5.  Skin colonization with vancomycin-resistant enterococci among hospitalized patients with bacteremia.

Authors:  D W Beezhold; S Slaughter; M K Hayden; M Matushek; C Nathan; G M Trenholme; R A Weinstein
Journal:  Clin Infect Dis       Date:  1997-04       Impact factor: 9.079

6.  Non-observance of guidelines for surgical antimicrobial prophylaxis and surgical-site infections.

Authors:  S Lallemand; M Thouverez; P Bailly; X Bertrand; D Talon
Journal:  Pharm World Sci       Date:  2002-06

7.  Assessment of prophylactic antibiotic use in patients with surgical site infections.

Authors:  Whitney J Goede; Jenna K Lovely; Rodney L Thompson; Robert R Cima
Journal:  Hosp Pharm       Date:  2013-07

8.  National nosocomial infections surveillance system (NNIS): description of surveillance methods.

Authors:  T G Emori; D H Culver; T C Horan; W R Jarvis; J W White; D R Olson; S Banerjee; J R Edwards; W J Martone; R P Gaynes
Journal:  Am J Infect Control       Date:  1991-02       Impact factor: 2.918

9.  A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resection.

Authors:  Ahmed Al-Mukhtar; Vincent K H Wong; Hassan Z Malik; Mohammed Abu-Hilal; Miles Denton; Mark Wilcox; J Peter A Lodge; Giles J Toogood; K Rajendra Prasad
Journal:  Ann R Coll Surg Engl       Date:  2009-01       Impact factor: 1.891

Review 10.  Methicillin-resistant Staphylococcus aureus (MRSA): colonisation and pre-operative screening.

Authors:  N Goyal; A Miller; M Tripathi; J Parvizi
Journal:  Bone Joint J       Date:  2013-01       Impact factor: 5.082

View more
  5 in total

Review 1.  Antibacterial Prophylaxis for Surgical Site Infection in the Elderly: Practical Application.

Authors:  Maria Adriana Cataldo; Guido Granata; Nicola Petrosillo
Journal:  Drugs Aging       Date:  2017-07       Impact factor: 3.923

2.  Distinction of Risk Factors for Superficial vs Organ-Space Surgical Site Infections After Pancreatic Surgery.

Authors:  Irmina A Elliott; Carmen Chan; Tara A Russell; Amanda M Dann; Jennifer L Williams; Lauren Damato; Hallie Chung; Mark D Girgis; O Joe Hines; Howard A Reber; Timothy R Donahue
Journal:  JAMA Surg       Date:  2017-11-01       Impact factor: 14.766

3.  A Novel Prediction Model for Bloodstream Infections in Hepatobiliary-Pancreatic Surgery Patients.

Authors:  Po-Sheng Yang; Chang-Pan Liu; Yi-Chiung Hsu; Chuen-Fei Chen; Chi-Chan Lee; Shih-Ping Cheng
Journal:  World J Surg       Date:  2019-05       Impact factor: 3.352

4.  Length of preoperative hospital stay is the dominating risk factor for surgical site infection in neurosurgery: A cohort data-driven analysis.

Authors:  Emilio Garzón Cediel; Varina Louise Boerwinkle; Juan Fernando Ramon; Diana Arias; Jose Antonio De la Hoz-Valle; Jose Dario Mercado; Darwin Cohen; Maria Claudia Niño
Journal:  Surg Neurol Int       Date:  2022-03-04

Review 5.  Repeat gram-negative hospital-acquired infections and antibiotic susceptibility: A systematic review.

Authors:  Mansi Agarwal; Stephanie Shiau; Elaine L Larson
Journal:  J Infect Public Health       Date:  2017-10-20       Impact factor: 3.718

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.